The global Pediatric Drugs and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
The Pediatric Drugs and Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Pediatric Drugs and Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
1 Pediatric Drugs and Vaccines Market Overview 1.1 Pediatric Drugs and Vaccines Product Scope 1.2 Pediatric Drugs and Vaccines Segment by Type1.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2016 & 2021 & 2027) 1.2.2 Diphtheria 1.2.3 Influenza 1.2.4 Hepatitis 1.2.5 Pneumococcal Diseases 1.2.6 Meningococcal Diseases 1.2.7 Mumps 1.2.8 Others 1.3 Pediatric Drugs and Vaccines Segment by Application1.3.1 Global Pediatric Drugs and Vaccines Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Newborn 1.3.3 Infant 1.3.4 Child 1.4 Pediatric Drugs and Vaccines Market Estimates and Forecasts (2016-2027)1.4.1 Global Pediatric Drugs and Vaccines Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Pediatric Drugs and Vaccines Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Pediatric Drugs and Vaccines Price Trends (2016-2027) 2 Pediatric Drugs and Vaccines Estimates and Forecasts by Region 2.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario by Region (2016-2021)2.2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2021) 2.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2021) 2.3 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Region (2022-2027)2.3.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures2.4.1 North America Pediatric Drugs and Vaccines Estimates and Projections (2016-2027) 2.4.2 Europe Pediatric Drugs and Vaccines Estimates and Projections (2016-2027) 2.4.3 China Pediatric Drugs and Vaccines Estimates and Projections (2016-2027) 2.4.4 Japan Pediatric Drugs and Vaccines Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Pediatric Drugs and Vaccines Estimates and Projections (2016-2027) 2.4.6 India Pediatric Drugs and Vaccines Estimates and Projections (2016-2027) 3 Global Pediatric Drugs and Vaccines Competition Landscape by Players 3.1 Global Top Pediatric Drugs and Vaccines Players by Sales (2016-2021) 3.2 Global Top Pediatric Drugs and Vaccines Players by Revenue (2016-2021) 3.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020) 3.4 Global Pediatric Drugs and Vaccines Average Price by Company (2016-2021) 3.5 Manufacturers Pediatric Drugs and Vaccines Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Pediatric Drugs and Vaccines Market Size by Type 4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021) 4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021) 4.1.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2021) 4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027) 4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027) 4.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027) 5 Global Pediatric Drugs and Vaccines Market Size by Application 5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021) 5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021) 5.1.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2021) 5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027) 5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027) 5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027) 6 North America Pediatric Drugs and Vaccines Market Facts & Figures 6.1 North America Pediatric Drugs and Vaccines Sales by Company6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2021) 6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2021) 6.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type6.2.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021) 6.2.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027) 6.3 North America Pediatric Drugs and Vaccines Sales Breakdown by Application6.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021) 6.3.2 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027) 7 Europe Pediatric Drugs and Vaccines Market Facts & Figures 7.1 Europe Pediatric Drugs and Vaccines Sales by Company7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2021) 7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2021) 7.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type7.2.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021) 7.2.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027) 7.3 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application7.3.1 Europe 143 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027) 8 China Pediatric Drugs and Vaccines Market Facts & Figures 8.1 China Pediatric Drugs and Vaccines Sales by Company8.1.1 China Pediatric Drugs and Vaccines Sales by Company (2016-2021) 8.1.2 China Pediatric Drugs and Vaccines Revenue by Company (2016-2021) 8.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type8.2.1 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021) 8.2.2 China Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027) 8.3 China Pediatric Drugs and Vaccines Sales Breakdown by Application8.3.1 China 163 Sales Breakdown by Application (2016-2021) 8.3.2 China 163 Sales Breakdown by Application (2022-2027) 9 Japan Pediatric Drugs and Vaccines Market Facts & Figures 9.1 Japan Pediatric Drugs and Vaccines Sales by Company9.1.1 Japan Pediatric Drugs and Vaccines Sales by Company (2016-2021) 9.1.2 Japan Pediatric Drugs and Vaccines Revenue by Company (2016-2021) 9.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type9.2.1 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021) 9.2.2 Japan Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027) 9.3 Japan Pediatric Drugs and Vaccines Sales Breakdown by Application9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Pediatric Drugs and Vaccines Market Facts & Figures 10.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company10.1.1 Southeast Asia Pediatric Drugs and Vaccines Sales by Company (2016-2021) 10.1.2 Southeast Asia Pediatric Drugs and Vaccines Revenue by Company (2016-2021) 10.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type10.2.1 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Pediatric Drugs and Vaccines Sales Breakdown by Application10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027) 11 India Pediatric Drugs and Vaccines Market Facts & Figures 11.1 India Pediatric Drugs and Vaccines Sales by Company11.1.1 India Pediatric Drugs and Vaccines Sales by Company (2016-2021) 11.1.2 India Pediatric Drugs and Vaccines Revenue by Company (2016-2021) 11.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type11.2.1 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2016-2021) 11.2.2 India Pediatric Drugs and Vaccines Sales Breakdown by Type (2022-2027) 11.3 India Pediatric Drugs and Vaccines Sales Breakdown by Application11.3.1 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2016-2021) 11.3.2 India Pediatric Drugs and Vaccines Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Pediatric Drugs and Vaccines Business 12.1 Merck & Co., Inc. (USA)12.1.1 Merck & Co., Inc. (USA) Corporation Information 12.1.2 Merck & Co., Inc. (USA) Business Overview 12.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered 12.1.5 Merck & Co., Inc. (USA) Recent Development 12.2 Abbott Laboratories (USA)12.2.1 Abbott Laboratories (USA) Corporation Information 12.2.2 Abbott Laboratories (USA) Business Overview 12.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered 12.2.5 Abbott Laboratories (USA) Recent Development 12.3 Amgen, Inc. (USA)12.3.1 Amgen, Inc. (USA) Corporation Information 12.3.2 Amgen, Inc. (USA) Business Overview 12.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered 12.3.5 Amgen, Inc. (USA) Recent Development 12.4 Eli Lilly and Company (USA)12.4.1 Eli Lilly and Company (USA) Corporation Information 12.4.2 Eli Lilly and Company (USA) Business Overview 12.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered 12.4.5 Eli Lilly and Company (USA) Recent Development 12.5 F. Hoffmann-La Roche Ltd (Switzerland)12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information 12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview 12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered 12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development 12.6 Genentech, Inc. (USA)12.6.1 Genentech, Inc. (USA) Corporation Information 12.6.2 Genentech, Inc. (USA) Business Overview 12.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered 12.6.5 Genentech, Inc. (USA) Recent Development 12.7 GlaxoSmithKline plc. (UK)12.7.1 GlaxoSmithKline plc. (UK) Corporation Information 12.7.2 GlaxoSmithKline plc. (UK) Business Overview 12.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered 12.7.5 GlaxoSmithKline plc. (UK) Recent Development 12.8 Janssen Biologics B.V. (USA)12.8.1 Janssen Biologics B.V. (USA) Corporation Information 12.8.2 Janssen Biologics B.V. (USA) Business Overview 12.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered 12.8.5 Janssen Biologics B.V. (USA) Recent Development 12.9 Actelion Pharmaceuticals12.9.1 Actelion Pharmaceuticals Corporation Information 12.9.2 Actelion Pharmaceuticals Business Overview 12.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered 12.9.5 Actelion Pharmaceuticals Recent Development 12.10 AstraZeneca Plc. (UK)12.10.1 AstraZeneca Plc. (UK) Corporation Information 12.10.2 AstraZeneca Plc. (UK) Business Overview 12.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered 12.10.5 AstraZeneca Plc. (UK) Recent Development 12.11 Boehringer Ingelheim GmbH (Germany)12.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information 12.11.2 Boehringer Ingelheim GmbH (Germany) Business Overview 12.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered 12.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development 12.12 Bristol-Myers Squibb Company (USA)12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information 12.12.2 Bristol-Myers Squibb Company (USA) Business Overview 12.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products Offered 12.12.5 Bristol-Myers Squibb Company (USA) Recent Development 12.13 Allergan, Inc. (USA)12.13.1 Allergan, Inc. (USA) Corporation Information 12.13.2 Allergan, Inc. (USA) Business Overview 12.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products Offered 12.13.5 Allergan, Inc. (USA) Recent Development 12.14 Novartis AG (Switzerland)12.14.1 Novartis AG (Switzerland) Corporation Information 12.14.2 Novartis AG (Switzerland) Business Overview 12.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products Offered 12.14.5 Novartis AG (Switzerland) Recent Development 12.15 Novo Nordisk A/S (Denmark)12.15.1 Novo Nordisk A/S (Denmark) Corporation Information 12.15.2 Novo Nordisk A/S (Denmark) Business Overview 12.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products Offered 12.15.5 Novo Nordisk A/S (Denmark) Recent Development 12.16 Pfizer, Inc. (USA)12.16.1 Pfizer, Inc. (USA) Corporation Information 12.16.2 Pfizer, Inc. (USA) Business Overview 12.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products Offered 12.16.5 Pfizer, Inc. (USA) Recent Development 12.17 Sanofi S.A (France)12.17.1 Sanofi S.A (France) Corporation Information 12.17.2 Sanofi S.A (France) Business Overview 12.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products Offered 12.17.5 Sanofi S.A (France) Recent Development 12.18 Shionogi Inc. (USA)12.18.1 Shionogi Inc. (USA) Corporation Information 12.18.2 Shionogi Inc. (USA) Business Overview 12.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products Offered 12.18.5 Shionogi Inc. (USA) Recent Development 12.19 Takeda12.19.1 Takeda Corporation Information 12.19.2 Takeda Business Overview 12.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Takeda Pediatric Drugs and Vaccines Products Offered 12.19.5 Takeda Recent Development 13 Pediatric Drugs and Vaccines Manufacturing Cost Analysis 13.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines 13.4 Pediatric Drugs and Vaccines Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Pediatric Drugs and Vaccines Distributors List 14.3 Pediatric Drugs and Vaccines Customers 15 Market Dynamics 15.1 Pediatric Drugs and Vaccines Market Trends 15.2 Pediatric Drugs and Vaccines Drivers 15.3 Pediatric Drugs and Vaccines Market Challenges 15.4 Pediatric Drugs and Vaccines Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List
Summary: Get latest Market Research Reports on Pediatric Drugs and Vaccines. Industry analysis & Market Report on Pediatric Drugs and Vaccines is a syndicated market report, published as Global Pediatric Drugs and Vaccines Sales Market Report 2021. It is complete Research Study and Industry Analysis of Pediatric Drugs and Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 01 June, 2021